Skip to content
Toggle main navigation
EndoForum logo
EndoForum logo
  • Join Today
    Log in
    Select an available language
    EN

    Endocrine News

    Endocrine News provides an in-depth look at trends in the field of endocrinology as well as a closer look at recently published research.

    Filter by category
    All
    Adrenal
    Advocacy
    Bone and Mineral
    Cardiometabolic
    Clinical
    COVID-19
    Diabetes
    Diabetes News and Research
    Diabetes Research Articles
    Early Career Corner
    See all

    Results (8)

    Measuring Up to Cancer: The Association Between the Degree of Hypercortisolism and Metastatic Disease

    Measuring Up to Cancer: The Association Between the Degree of Hypercortisolism and Metastatic Disease

    Adrenal tumor size and the severity of cortisol excess are associated with a higher risk of metastatic disease at diagnosis, according to a study recently published in The Journal of Clinical Endocrinology & Metabolism. Researchers led by Marta Arajuo-Castro, of Hospital Universitario Ramon y Cajal in Madrid, Spain, point out in their article, “Severity and […]The post Measuring Up to Cancer: The
    October 12, 2026
    Moving Targets: Epigenetics and Disease Progression in Neuroendocrine Neoplasms

    Moving Targets: Epigenetics and Disease Progression in Neuroendocrine Neoplasms

    Neuroendocrine neoplasms (NENs) can show up anywhere in the body and can impact any organ system. These tumors originate in diverse sites, according to the authors of a recently published paper in Endocrine Reviews, which kind of makes them moving targets. Authors of the paper, “Epigenetics and disease progression in neuroendocrine neoplasms,” led by Madson […]The post Moving Targets: Epigenetics
    October 5, 2026
    Double Trouble: Functional Suppression of a Prolactinoma by a Dopamine-Secreting Paraganglioma

    Double Trouble: Functional Suppression of a Prolactinoma by a Dopamine-Secreting Paraganglioma

    A recent JCEM Case Reports article describes a 52-year-old male who presented with cerebrospinal fluid rhinorrhea and was found to have an invasive, 4.2-cm pituitary mass with modestly elevated prolactin. When the surgeons resected the tumor, it revealed another. Two rare endocrine tumors occurring recurrently. Endocrine News speaks with the lead author, who shared the […]The post Double Trouble:
    September 22, 2026
    A Flexible Algorithm for a Variable Disease: Treating Pheochromocytoma and Paraganglioma

    A Flexible Algorithm for a Variable Disease: Treating Pheochromocytoma and Paraganglioma

    Endocrine News speaks with Camilo Jimenez, MD, about his JCEM paper “Approach to the patient with metastatic pheochromocytoma and paraganglioma: advances in systemic therapy” that focuses on treating a patient with pheochromocytomas and paragangliomas, its complexity, and his team’s algorithm that created a novel approach to guiding treatment decisions. Pheochromocytomas and paragangliomas (PPGLs)
    September 14, 2026
    July 2026 Dashboard

    July 2026 Dashboard

    Highlights from the world of endocrinology 15% The percentage by which fractures decreased when using semaglutide as compared to other weight-loss strategies. Semaglutide also appeared to help the most with weight loss in patients with diabetes. Source: ENDO 2026 presentation by Sun H. Kim, MD, MS, associate professor of medicine in the Division of Endocrinology, […]The post July 2026 Dashboard ap
    July 21, 2026
    Towards a Shared Language: Defining endocrine-immune-related adverse events

    Towards a Shared Language: Defining endocrine-immune-related adverse events

    On behalf of the Endocrine Society’s Oncoendocrinology Special Interest Group, Ling Zhu, MBBChir, discusses her recent paper that addressed “the gap in standardized nomenclature, clinical, laboratory and radiological evaluations, and management principles of endocrine- immune-related adverse events (E-irAEs).” She also talks to corresponding author, Afreen Shariff, MD, about the need for nomenclat
    November 13, 2025
    String of Pearls: A Look at Rare Clinical Pearls from JCEM Case Reports

    String of Pearls: A Look at Rare Clinical Pearls from JCEM Case Reports

    The JCEM Case Reports Clinical Pearls session at ENDO 2025 featured three presentations of rare challenging endocrine cases that could answer questions for endocrinologists who could be treating patients with similar symptoms, possibly triggering further investigations that might lead to optimal outcomes. The audience for the third-annual JCEM Case Reports Clinical Pearls session at ENDO 2025 in S
    October 16, 2025
    From Growth to Cancer: The Double Life of Growth Hormone

    From Growth to Cancer: The Double Life of Growth Hormone

    A growing body of research reveals that growth hormone (GH), long known for its role in growth and development, may have a darker side — one that could be manipulated for therapeutic benefit in cancer. A comprehensive review published in Endocrine Reviews spotlights the role of GH in cancer development and progression and evaluates the promise of GH-targeted therapies.The pituitary gland tradition
    July 7, 2025
    Contact
    1 (888) 363-6762
    Cookies
    Reselect cookie settings
    Community engagement platform by Hivebrite.